In vivo dopamine (DA) receptor binding and behavioural effects of the putative DA autoreceptor antagonists (+)-AJ 76 and (+)-UH 232 in rats with a unilateral nigral 6-OH-DA lesion
- PMID: 3133239
- DOI: 10.1007/BF00247605
In vivo dopamine (DA) receptor binding and behavioural effects of the putative DA autoreceptor antagonists (+)-AJ 76 and (+)-UH 232 in rats with a unilateral nigral 6-OH-DA lesion
Abstract
The in vivo dopamine (DA) receptor binding and behavioural properties of the recently characterised putative preferential DA autoreceptor antagonists (+)-AJ 76 and (+)-UH 232 were studied in rats with a unilateral 6-OH-DA lesion of the substantia nigra. The main findings were a) that (+)-UH 232 and (+)-AJ 76 per se failed to produce significant turning behaviour, b) that both agents antagonised contralateral rotation caused by the DA agonist apomorphine, including a change of the characteristic two-peak apomorphine rotation pattern into a single peak, indicating that the DA antagonist properties of (+)-UH 232 and (+)-AJ 76 are retained also at denervation-sensitised postsynaptic DA receptors and--in support of this notion--c) that (+)-UH 232 and (+)-AJ 76 were able to displace the specific in vivo binding of the DA receptor agonist DP-5,6-ADTN in the denervated as well as in the intact striata of the 6-OH-DA-lesioned animals. Interestingly, in this regard (+)-UH 232 was significantly less efficient on the lesioned as compared to the intact side. The DP-5,6-ADTN-displacing effect of (+)-AJ 76 did not, however, differ between the intact and the denervated striatum. The implications of the present findings are discussed with particular reference to DA receptor sensitivity and adaptational phenomena.
Similar articles
-
(+)-AJ 76 and (+)-UH 232: central stimulants acting as preferential dopamine autoreceptor antagonists.Naunyn Schmiedebergs Arch Pharmacol. 1986 Nov;334(3):234-45. doi: 10.1007/BF00508777. Naunyn Schmiedebergs Arch Pharmacol. 1986. PMID: 2880302
-
Electrophysiological effects of dopamine autoreceptor antagonists, (+)-AJ 76 and (+)-UH 232.Eur J Pharmacol. 1990 Jul 3;182(2):219-26. doi: 10.1016/0014-2999(90)90280-j. Eur J Pharmacol. 1990. PMID: 2397740
-
The putatively selective dopamine autoreceptor antagonists (+)-AJ 76 and (+)-UH 232 stimulate prolactin release in rats.Eur J Pharmacol. 1986 Nov 4;130(3):237-42. doi: 10.1016/0014-2999(86)90273-6. Eur J Pharmacol. 1986. PMID: 3792447
-
Dopamine receptor agonists: mechanisms underlying autoreceptor selectivity. II. Theoretical considerations.J Neural Transm. 1985;62(3-4):171-207. doi: 10.1007/BF01252236. J Neural Transm. 1985. PMID: 2863323 Review.
-
On the mechanism of the antiparkinsonian action of 1-DOPA and bromocriptine: a theoretical and experimental analysis of dopamine receptor sub- and supersensitivity.J Neural Transm Suppl. 1980;(16):69-81. doi: 10.1007/978-3-7091-8582-7_8. J Neural Transm Suppl. 1980. PMID: 7000979 Review.
Cited by
-
Differential effects of dopamine D2 and D3 receptor antagonists in regard to dopamine release, in vivo receptor displacement and behaviour.J Neural Transm Gen Sect. 1994;98(1):39-55. doi: 10.1007/BF01277593. J Neural Transm Gen Sect. 1994. PMID: 7710738
-
Effects of the putative dopamine autoreceptor antagonists (+)-AJ 76 and (+)-UH 232 on the discriminative stimulus properties of cocaine.Psychopharmacology (Berl). 1992;107(1):73-7. doi: 10.1007/BF02244968. Psychopharmacology (Berl). 1992. PMID: 1589564